Charles Schwab Investment Management »

Cerevel Therapeutics Hldng I shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $28M 649k 42.40
2023-09-30 $11M 517k 21.83
2023-06-30 $16M 502k 31.79
2023-03-31 $12M 487k 24.39
2022-12-31 $15M 485k 31.54
2022-09-30 $13M 468k 28.26
2022-06-30 $11M 396k 26.44
2022-03-31 $13M 373k 35.01
2021-12-31 $12M 363k 32.42
2021-09-30 $10M 352k 29.50
2021-06-30 $6.4M 252k 25.62
2021-03-31 $2.4M 172k 13.74
2020-12-31 $2.8M 167k 16.59